Search - tctmd.com

Displaying 21 - 40 of 83

Sort: Relevancy | Date

Presentation TCT 2022

TCT 51: Assessment of Durable Polymer and Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction

Presenter: Gustavo Araújo

September 17, 2022

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT 2020

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

Presenter: Prakash Ajmera

October 14, 2020

Presentation TCT 2020

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

Presenter: Sridhar Kasturi, MD

October 14, 2020

Presentation TCT Abstracts Posters 2019

A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer Coated Ultra-Thin Everolimus-Eluting Stents: One-year Results From the PERFORM-EVER Registry

Presenter: Sridhar Kasturi

October 09, 2019

Presentation TCT 2019

1-Year Clinical Outcomes of World’s Thinnest (50 Microns) Biodegradable Polymer-Coated Everolimus-Eluting Coronary Stent in Patients With Coronary Artery Disease

Presenter: K. Sivaprasad

September 27, 2019

Presentation TCT 2019

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Presenter: Takeshi Kimura

September 26, 2019

Presentation

Biodegradable-Polymer Synergy vs Durable-Polymer Xience for PCI in Clinical Practice

August 14, 2019

Presentation CIT 2019

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Presenter: Bin Wang, Yaling Han

March 28, 2019

Presentation TCT Abstracts Posters 2018

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Presenter: Woo-Young Chung

September 25, 2018

Presentation TCT Abstracts Posters 2018

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

Presenter: Imanol Otaegui

September 25, 2018

Presentation TCT 2018

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Michael Haude, Robert-Jan van Geuns, Yaling Han

September 23, 2018

Presentation TCT 2018

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert

September 21, 2018

Presentation TCT 2017

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Piotr P. Buszman

November 01, 2017

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Pieter C. Smits

October 31, 2016

Presentation TCT 2016

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Li Zhi

October 31, 2016

Presentation TCT 2016

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Presenter: Stephan Windecker, Michael Joner

October 31, 2016

Presentation TCT 2016

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen

October 30, 2016

Presentation CCVVC 2016

Biodegradable vs Durable Polymer DES Outcomes

Presenter: Ajay J. Kirtane

June 16, 2016

Advertisement

TCT 51: Assessment of Durable Polymer and Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer Coated Ultra-Thin Everolimus-Eluting Stents: One-year Results From the PERFORM-EVER Registry

1-Year Clinical Outcomes of World’s Thinnest (50 Microns) Biodegradable Polymer-Coated Everolimus-Eluting Coronary Stent in Patients With Coronary Artery Disease

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Biodegradable-Polymer Synergy vs Durable-Polymer Xience for PCI in Clinical Practice

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Biodegradable vs Durable Polymer DES Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content